Latanoprost eye drops induce conjunctival lymphatic vessel development.

Area of Science:

• Ophthalmology
• Vascular Biology
• Pharmacology

Background:

• Conjunctival lymphatics play a crucial role in ocular fluid homeostasis and immune surveillance.
• Understanding the molecular mechanisms regulating conjunctival lymphatic function is essential for developing novel therapeutic strategies.

Purpose of the Study:

• To investigate the effect of latanoprost eye drops on conjunctival lymphatics in a rabbit model.
• To explore the role of 5 -nucleotidase (5 -Nase) in latanoprost-induced changes in conjunctival lymphatic vessels.

Main Methods:

• New Zealand White rabbits were divided into three groups: latanoprost, carteolol, and control.
• Conjunctival tissues were analyzed for 5 -Nase expression using Western blot, RT-PCR, and immunofluorescence staining.

Main Results:

• Latanoprost significantly upregulated both protein and mRNA expression of 5 -Nase in conjunctival tissues compared to control and carteolol groups.
• Immunofluorescence staining confirmed positive 5 -Nase expression in conjunctival lymphatics of the latanoprost group, suggesting lymphangiogenesis.

Conclusions:

• Latanoprost eye drops promote conjunctival lymphangiogenesis.
• The observed induction of conjunctival lymphatics by latanoprost may have significant clinical implications in ophthalmology.